Placebo for Azithromycin

DRUG3 trials

Sponsors

Rigshospitalet, Penang Hospital, Malaysia, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

BronchiectasisBronchoPulmonary DysplasiaCOVID-19Chronic AtelectasisCystic Lung MalformationsLobar Hyperinflation SyndromePost-Vascular Ring with central airway compressionSARS-CoV 2

Phase 2

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

TerminatedNCT04358068

National Institute of Allergy and Infectious Diseases (NIAID)COVID-19, SARS-CoV 2

Start: 2020-05-13End: 2020-07-08Updated: 2021-11-16

Phase 4

Efficacy of Azithromycin in Treatment of Bronchiectasis

CompletedNCT02107274

Penang Hospital, MalaysiaBronchiectasis

Start: 2011-11-30End: 2013-12-31Updated: 2014-07-18

Enhancing Lung Health in Kids with structural Lung Damage and Malformations: a randomized controlled trial on Azithromycin (AZI) for Airway Infection Prevention

Not yet recruitingCTIS2024-518730-88-00

RigshospitaletBronchiectasis, BronchoPulmonary Dysplasia, Chronic Atelectasis +4

Target: 150Updated: 2025-11-14

Related Papers

Efficacy of azithromycin in the treatment of bronchiectasis

Respirology2014-09-0224 citations